BRPI0911083A8 - métodos para o tratamento ou prevenção da diabetes mellitus e outros desequilíbrios metabólicos - Google Patents

métodos para o tratamento ou prevenção da diabetes mellitus e outros desequilíbrios metabólicos Download PDF

Info

Publication number
BRPI0911083A8
BRPI0911083A8 BRPI0911083A BRPI0911083A BRPI0911083A8 BR PI0911083 A8 BRPI0911083 A8 BR PI0911083A8 BR PI0911083 A BRPI0911083 A BR PI0911083A BR PI0911083 A BRPI0911083 A BR PI0911083A BR PI0911083 A8 BRPI0911083 A8 BR PI0911083A8
Authority
BR
Brazil
Prior art keywords
treating
methods
diabetes mellitus
preventing diabetes
metabolic imbalances
Prior art date
Application number
BRPI0911083A
Other languages
English (en)
Inventor
Sundram Kalyana
C Hayes Kenneth
Sambanthamurthi Ravigadevi
Ai Tan Yew
Original Assignee
Univ Brandeis
Malaysian Palm Oil Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brandeis, Malaysian Palm Oil Board filed Critical Univ Brandeis
Publication of BRPI0911083A2 publication Critical patent/BRPI0911083A2/pt
Publication of BRPI0911083A8 publication Critical patent/BRPI0911083A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BRPI0911083A 2008-04-02 2009-04-02 métodos para o tratamento ou prevenção da diabetes mellitus e outros desequilíbrios metabólicos BRPI0911083A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/080,361 US8071143B2 (en) 2008-04-02 2008-04-02 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
PCT/US2009/039296 WO2009146102A1 (en) 2008-04-02 2009-04-02 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances

Publications (2)

Publication Number Publication Date
BRPI0911083A2 BRPI0911083A2 (pt) 2015-10-06
BRPI0911083A8 true BRPI0911083A8 (pt) 2018-08-28

Family

ID=41133491

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911083A BRPI0911083A8 (pt) 2008-04-02 2009-04-02 métodos para o tratamento ou prevenção da diabetes mellitus e outros desequilíbrios metabólicos

Country Status (11)

Country Link
US (2) US8071143B2 (pt)
EP (1) EP2288364B1 (pt)
JP (3) JP2011518131A (pt)
CN (1) CN102088988B (pt)
AU (1) AU2009251568B2 (pt)
BR (1) BRPI0911083A8 (pt)
DK (1) DK2288364T3 (pt)
ES (1) ES2474726T3 (pt)
MY (1) MY153112A (pt)
PL (1) PL2288364T3 (pt)
WO (1) WO2009146102A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY161839A (en) 2009-05-18 2017-05-15 Malaysian Palm Oil Board A composition for use in the prevention and treatment of cardiovascular diseases
MY173655A (en) 2009-06-09 2020-02-14 Malaysian Palm Oil Board Composition and method for improving vascular health
MY185582A (en) * 2010-01-07 2021-05-24 Malaysian Palm Oil Board Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atheroslerosis and cardiovascular disease
CN101982115A (zh) * 2010-10-14 2011-03-02 张丽娜 一种防治糖尿病慢性糖中毒的组合物
MY175348A (en) * 2011-02-11 2020-06-22 Crea Roberto Treatment of elaeis fruit products with antioxidants
EP2709643B1 (en) * 2011-05-18 2018-05-16 Malaysian Palm Oil Board Compositions comprising extracts or materials derived from palm oil vegetation liguor for inhibition of vision loss due to macular degeneration
US20150030710A1 (en) 2011-05-18 2015-01-29 Malaysian Palm Oil Board Compositions comprising extracts or materials derived from palm oil vegetation liquor for inhibition of vision loss due to angiogenesis and method of preparation there
CA2857374A1 (en) 2011-09-02 2013-03-07 The Trustees Of Columbia University In The City Of New York Camkii, ip3r, calcineurin, p38 and mk2/3 inhibitors to treat metabolic disturbances of obesity
MY179036A (en) * 2012-12-13 2020-10-26 Malaysian Palm Oil Board Anti-proliferative effects of palm vegetation liquor and extracts thereof in preventing pancreatic cancer
EA201591476A1 (ru) * 2013-02-06 2016-02-29 Университет Брандайс Лечение повреждений днк и митохондриальной дисфункции с применением сока плодов масличной пальмы
ES2936094T3 (es) * 2016-06-13 2023-03-14 Syneurx Int Taiwan Corp Cocristales de benzoato de sodio y usos de los mismos
RU2765625C2 (ru) * 2016-06-13 2022-02-01 Сайньюрекс Интернэшнл (Тайвань) Корп. Сокристаллы бензоата лития и их применения
CN108355034A (zh) * 2018-05-02 2018-08-03 黑龙江中医药大学 一种用于治疗多囊卵巢综合征着床障碍的中药制剂及其制备方法
CN109464561A (zh) * 2018-10-09 2019-03-15 昆明理工大学 棕榈果提取物的用途
CN109172712A (zh) * 2018-10-09 2019-01-11 昆明理工大学 棕榈果提取物的用途
WO2023047317A1 (en) * 2021-09-23 2023-03-30 Alkalay Rachel Compositions and methods for treating or preventing inflammatory diseases including diabetes and thyroid diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126474A (en) * 1996-04-12 2001-03-19 Beth Israel Hospital Diabetic supplement bar
MY134878A (en) 1998-09-24 2007-12-31 Palm Oil Res And Dev Board Treatment of liquors derived from oil-bearing fruit.
CA2442106A1 (en) 2001-03-29 2002-10-10 Basf Aktiengesellschaft Conjugated unsaturated glyceride mixtures and a method for producing the same
JP4324335B2 (ja) * 2001-09-07 2009-09-02 花王株式会社 カテキン含有飲料
JP2003095942A (ja) * 2001-09-21 2003-04-03 Ito En Ltd 脂肪細胞におけるグルコース取込阻害剤及びｇｌｕｔ４トランスロケーション抑制剤、筋肉細胞におけるグルコース取込活性化剤並びに脂肪軽減飲食物
EP2243383A3 (en) * 2005-04-06 2011-02-16 Nestec S.A. A method and composition for nutritionally improving glucose control and insulin action

Also Published As

Publication number Publication date
JP2011518131A (ja) 2011-06-23
JP6421961B2 (ja) 2018-11-14
US8071143B2 (en) 2011-12-06
EP2288364A1 (en) 2011-03-02
US20090252817A1 (en) 2009-10-08
MY153112A (en) 2014-12-31
DK2288364T3 (da) 2014-05-26
US9326957B2 (en) 2016-05-03
JP2017186354A (ja) 2017-10-12
CN102088988A (zh) 2011-06-08
ES2474726T3 (es) 2014-07-09
JP2014193930A (ja) 2014-10-09
US20120114775A1 (en) 2012-05-10
AU2009251568B2 (en) 2014-08-14
AU2009251568A1 (en) 2009-12-03
EP2288364A4 (en) 2011-06-01
PL2288364T3 (pl) 2014-08-29
BRPI0911083A2 (pt) 2015-10-06
CN102088988B (zh) 2013-05-29
EP2288364B1 (en) 2014-03-26
WO2009146102A1 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
BRPI0911083A8 (pt) métodos para o tratamento ou prevenção da diabetes mellitus e outros desequilíbrios metabólicos
BRPI1013992A2 (pt) composições e métodos para o tratamento de resistência à insulina e diabetes melito
BRPI0920326A2 (pt) composição e método para tratamento da síndrome do olho ressecado
BRPI0919288A2 (pt) teriapia de combinação para tratamento de diabetes e condições relacionadas.
BRPI0921317A2 (pt) composto, composição farmacêutica, e, método para tratar ou prevenir uma patologia relacionada com abeta em um mamífero
BRPI0906549A2 (pt) Bandagens médicas com válvulas e kits contendo as mesmas.
BRPI1006145A2 (pt) "composição e método para tratamento de diabetes".
TWI370390B (en) Microprocessors and methods for executing macroinstructions
BRPI0921022A2 (pt) tratamento com pirfenidona para pacientes com função hepática atípica
BRPI0915282A2 (pt) agonistas mistos baseados no gip para o tratamento de distúrbios metabólicos e obesidade
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0910406A2 (pt) equipamento e métodos para otmimização de tranporte para entrega de conteúdo widget
BRPI0911757A2 (pt) composiÇÕes e mÉtodos para tratar distérbios digestivos.
BRPI0919575A2 (pt) método, e, composição
BRPI0808163A2 (pt) Composição para aplicação tópica, métodos para tratar uma condição de superfície em um indivíduo, para preparar uma composição, e para usar o kit, e, kit
BRPI0910282A2 (pt) Composto oxadiazo-antraceno para o tratamento de diabetes
BRPI0823277A2 (pt) Composição, e , método
BRPI0919804A2 (pt) Métodos e composição para o tratemento de problemas dermatológicos e/ou condições de cabelo
BRPI1014185A2 (pt) fecho com substância aromática
BRPI0809573A2 (pt) composição, e, método
BRPI0905369A2 (pt) Composição farmacêutica, composição e kit compartimentado
BRPI0822914A2 (pt) Composição, filme e métodos relacionados
FI20095893L (fi) Kovettuva koostumus, kovettunut tuote sekä laminaatti
BRPI0906094A2 (pt) composto e método de tratamento de diabetes do tipo ii
FI20070935A0 (fi) Koostumus ja menetelmä puun käsittelemiseksi

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.1 NA RPI NO 2611 DE 19/01/2021 POR TER SIDO INDEVIDA.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time